The FDA has been holding public meetings on 20 different disease areas, one disease per area over the last year or so to continue through 2017. Alopecia Areata is on a preliminary list to be chosen as a disease in the FDA’s process for patient-focused input for the 2016-2017 disease-specific meetings. The FDA is currently inviting commentary on this preliminary list.
- Bald Girls Do Lunch is giving our network a quick way to give feedback to the FDA.
- The FDA staff wants your views to better understand patients’ opinions about which diseases patients consider to be a high priority.
- Our easy form and quick guidelines will focus your feedback. Act now!
Submit your feedback by December 5th, 2014.